Stay updated on Resmetirom Safety and Biomarkers Clinical Trial

Sign up to get notified when there's something new on the Resmetirom Safety and Biomarkers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Resmetirom Safety and Biomarkers Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now displays the ClinicalTrials.gov record for the completed resmetirom Phase 3 study, including its design, eligibility criteria, outcomes, locations, and publications, in place of a 403 error page.
    Difference
    86%
    Check dated 2026-11-08T15:00:51.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0; the study record remains inaccessible behind a 403 error.
    Difference
    0.2%
    Check dated 2026-11-01T16:12:51.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces an update to terminology, stating that “Super Intelligence” will be used in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-25T15:16:15.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T15:27:40.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T15:23:49.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The MAESTRO-NAFLD-1 trial page now displays a 403 Forbidden error, replacing the full study record and its details with an access block. Users cannot view the trial's title, identifiers, conditions, locations, or dates.
    Difference
    18%
    Check dated 2026-09-20T19:39:58.000Z thumbnail image

Stay in the know with updates to Resmetirom Safety and Biomarkers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Resmetirom Safety and Biomarkers Clinical Trial page.